nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminocaproic Acid—PLAT—type 2 diabetes mellitus	0.652	1	CbGaD
Aminocaproic Acid—PLG—tunica intima—type 2 diabetes mellitus	0.0209	0.292	CbGeAlD
Aminocaproic Acid—PLG—artery—type 2 diabetes mellitus	0.00714	0.1	CbGeAlD
Aminocaproic Acid—PLG—endothelium—type 2 diabetes mellitus	0.00603	0.0845	CbGeAlD
Aminocaproic Acid—PLG—retina—type 2 diabetes mellitus	0.00293	0.0411	CbGeAlD
Aminocaproic Acid—PLAT—islet of Langerhans—type 2 diabetes mellitus	0.00292	0.0409	CbGeAlD
Aminocaproic Acid—PLG—nephron tubule—type 2 diabetes mellitus	0.00276	0.0387	CbGeAlD
Aminocaproic Acid—PLAT—retina—type 2 diabetes mellitus	0.00249	0.0349	CbGeAlD
Aminocaproic Acid—PLG—cardiovascular system—type 2 diabetes mellitus	0.00248	0.0348	CbGeAlD
Aminocaproic Acid—PLG—kidney—type 2 diabetes mellitus	0.00243	0.034	CbGeAlD
Aminocaproic Acid—PLG—cortex of kidney—type 2 diabetes mellitus	0.00236	0.0331	CbGeAlD
Aminocaproic Acid—PLAT—nephron tubule—type 2 diabetes mellitus	0.00235	0.0329	CbGeAlD
Aminocaproic Acid—PLAT—pancreas—type 2 diabetes mellitus	0.00205	0.0287	CbGeAlD
Aminocaproic Acid—PLAT—cortex of kidney—type 2 diabetes mellitus	0.00201	0.0282	CbGeAlD
Aminocaproic Acid—PLAT—adipose tissue—type 2 diabetes mellitus	0.00186	0.0261	CbGeAlD
Aminocaproic Acid—AOX1—islet of Langerhans—type 2 diabetes mellitus	0.00158	0.0221	CbGeAlD
Aminocaproic Acid—PLG—liver—type 2 diabetes mellitus	0.00153	0.0215	CbGeAlD
Aminocaproic Acid—PLAT—liver—type 2 diabetes mellitus	0.0013	0.0183	CbGeAlD
Aminocaproic Acid—AOX1—nephron tubule—type 2 diabetes mellitus	0.00127	0.0178	CbGeAlD
Aminocaproic Acid—AOX1—kidney—type 2 diabetes mellitus	0.00111	0.0156	CbGeAlD
Aminocaproic Acid—AOX1—pancreas—type 2 diabetes mellitus	0.00111	0.0155	CbGeAlD
Aminocaproic Acid—AOX1—cortex of kidney—type 2 diabetes mellitus	0.00109	0.0152	CbGeAlD
Aminocaproic Acid—AOX1—adipose tissue—type 2 diabetes mellitus	0.001	0.0141	CbGeAlD
Aminocaproic Acid—AOX1—liver—type 2 diabetes mellitus	0.000705	0.00988	CbGeAlD
Aminocaproic Acid—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000282	0.0021	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.000281	0.00209	CcSEcCtD
Aminocaproic Acid—Malaise—Gliclazide—type 2 diabetes mellitus	0.00028	0.00208	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.00028	0.00208	CcSEcCtD
Aminocaproic Acid—Rash—Repaglinide—type 2 diabetes mellitus	0.000279	0.00208	CcSEcCtD
Aminocaproic Acid—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000279	0.00208	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.000279	0.00207	CcSEcCtD
Aminocaproic Acid—Leukopenia—Gliclazide—type 2 diabetes mellitus	0.000278	0.00207	CcSEcCtD
Aminocaproic Acid—Headache—Repaglinide—type 2 diabetes mellitus	0.000277	0.00206	CcSEcCtD
Aminocaproic Acid—Shock—Glyburide—type 2 diabetes mellitus	0.000277	0.00206	CcSEcCtD
Aminocaproic Acid—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000277	0.00206	CcSEcCtD
Aminocaproic Acid—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.000276	0.00205	CcSEcCtD
Aminocaproic Acid—Agranulocytosis—Losartan—type 2 diabetes mellitus	0.000275	0.00205	CcSEcCtD
Aminocaproic Acid—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.000275	0.00205	CcSEcCtD
Aminocaproic Acid—Loss of consciousness—Gliclazide—type 2 diabetes mellitus	0.000273	0.00203	CcSEcCtD
Aminocaproic Acid—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.00027	0.00201	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.00027	0.00201	CcSEcCtD
Aminocaproic Acid—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000269	0.00201	CcSEcCtD
Aminocaproic Acid—Convulsion—Gliclazide—type 2 diabetes mellitus	0.000269	0.002	CcSEcCtD
Aminocaproic Acid—Myalgia—Gliclazide—type 2 diabetes mellitus	0.000264	0.00197	CcSEcCtD
Aminocaproic Acid—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000264	0.00196	CcSEcCtD
Aminocaproic Acid—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000264	0.00196	CcSEcCtD
Aminocaproic Acid—Hypotension—Glyburide—type 2 diabetes mellitus	0.000263	0.00196	CcSEcCtD
Aminocaproic Acid—Nausea—Repaglinide—type 2 diabetes mellitus	0.000263	0.00196	CcSEcCtD
Aminocaproic Acid—Tinnitus—Irbesartan—type 2 diabetes mellitus	0.000262	0.00195	CcSEcCtD
Aminocaproic Acid—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000262	0.00195	CcSEcCtD
Aminocaproic Acid—Ill-defined disorder—Orlistat—type 2 diabetes mellitus	0.000261	0.00194	CcSEcCtD
Aminocaproic Acid—Discomfort—Gliclazide—type 2 diabetes mellitus	0.000261	0.00194	CcSEcCtD
Aminocaproic Acid—Pruritus—Glipizide—type 2 diabetes mellitus	0.000259	0.00193	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000259	0.00192	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.000257	0.00191	CcSEcCtD
Aminocaproic Acid—Syncope—Valsartan—type 2 diabetes mellitus	0.000256	0.0019	CcSEcCtD
Aminocaproic Acid—Confusional state—Gliclazide—type 2 diabetes mellitus	0.000255	0.0019	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000254	0.00189	CcSEcCtD
Aminocaproic Acid—Malaise—Orlistat—type 2 diabetes mellitus	0.000254	0.00189	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000252	0.00188	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000252	0.00187	CcSEcCtD
Aminocaproic Acid—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000251	0.00187	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000251	0.00187	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000251	0.00187	CcSEcCtD
Aminocaproic Acid—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.00025	0.00186	CcSEcCtD
Aminocaproic Acid—Renal failure—Ramipril—type 2 diabetes mellitus	0.000249	0.00185	CcSEcCtD
Aminocaproic Acid—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000249	0.00185	CcSEcCtD
Aminocaproic Acid—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000248	0.00184	CcSEcCtD
Aminocaproic Acid—Tinnitus—Losartan—type 2 diabetes mellitus	0.000247	0.00184	CcSEcCtD
Aminocaproic Acid—Convulsion—Orlistat—type 2 diabetes mellitus	0.000244	0.00182	CcSEcCtD
Aminocaproic Acid—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000244	0.00181	CcSEcCtD
Aminocaproic Acid—Myalgia—Valsartan—type 2 diabetes mellitus	0.000243	0.00181	CcSEcCtD
Aminocaproic Acid—Dizziness—Glipizide—type 2 diabetes mellitus	0.000242	0.0018	CcSEcCtD
Aminocaproic Acid—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000242	0.0018	CcSEcCtD
Aminocaproic Acid—Ill-defined disorder—Metformin—type 2 diabetes mellitus	0.000241	0.00179	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.00024	0.00179	CcSEcCtD
Aminocaproic Acid—Myalgia—Orlistat—type 2 diabetes mellitus	0.00024	0.00178	CcSEcCtD
Aminocaproic Acid—Discomfort—Orlistat—type 2 diabetes mellitus	0.000237	0.00176	CcSEcCtD
Aminocaproic Acid—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000237	0.00176	CcSEcCtD
Aminocaproic Acid—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000236	0.00176	CcSEcCtD
Aminocaproic Acid—Malaise—Metformin—type 2 diabetes mellitus	0.000234	0.00174	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000234	0.00174	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000233	0.00174	CcSEcCtD
Aminocaproic Acid—Vomiting—Glipizide—type 2 diabetes mellitus	0.000233	0.00173	CcSEcCtD
Aminocaproic Acid—Syncope—Metformin—type 2 diabetes mellitus	0.000233	0.00173	CcSEcCtD
Aminocaproic Acid—Oedema—Valsartan—type 2 diabetes mellitus	0.000233	0.00173	CcSEcCtD
Aminocaproic Acid—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000233	0.00173	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000232	0.00173	CcSEcCtD
Aminocaproic Acid—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000232	0.00173	CcSEcCtD
Aminocaproic Acid—Rash—Glipizide—type 2 diabetes mellitus	0.000231	0.00172	CcSEcCtD
Aminocaproic Acid—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000231	0.00172	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000231	0.00172	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000231	0.00172	CcSEcCtD
Aminocaproic Acid—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.00023	0.00171	CcSEcCtD
Aminocaproic Acid—Oedema—Orlistat—type 2 diabetes mellitus	0.00023	0.00171	CcSEcCtD
Aminocaproic Acid—Headache—Glipizide—type 2 diabetes mellitus	0.00023	0.00171	CcSEcCtD
Aminocaproic Acid—Shock—Valsartan—type 2 diabetes mellitus	0.000229	0.0017	CcSEcCtD
Aminocaproic Acid—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000228	0.0017	CcSEcCtD
Aminocaproic Acid—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000228	0.0017	CcSEcCtD
Aminocaproic Acid—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.000227	0.00169	CcSEcCtD
Aminocaproic Acid—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000226	0.00168	CcSEcCtD
Aminocaproic Acid—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000226	0.00168	CcSEcCtD
Aminocaproic Acid—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000225	0.00168	CcSEcCtD
Aminocaproic Acid—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000223	0.00166	CcSEcCtD
Aminocaproic Acid—Myalgia—Metformin—type 2 diabetes mellitus	0.000221	0.00164	CcSEcCtD
Aminocaproic Acid—Malaise—Irbesartan—type 2 diabetes mellitus	0.000221	0.00164	CcSEcCtD
Aminocaproic Acid—Headache—Pioglitazone—type 2 diabetes mellitus	0.00022	0.00164	CcSEcCtD
Aminocaproic Acid—Syncope—Irbesartan—type 2 diabetes mellitus	0.00022	0.00163	CcSEcCtD
Aminocaproic Acid—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000219	0.00163	CcSEcCtD
Aminocaproic Acid—Discomfort—Metformin—type 2 diabetes mellitus	0.000218	0.00162	CcSEcCtD
Aminocaproic Acid—Nausea—Glipizide—type 2 diabetes mellitus	0.000218	0.00162	CcSEcCtD
Aminocaproic Acid—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000217	0.00162	CcSEcCtD
Aminocaproic Acid—Hypotension—Valsartan—type 2 diabetes mellitus	0.000217	0.00162	CcSEcCtD
Aminocaproic Acid—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000217	0.00161	CcSEcCtD
Aminocaproic Acid—Pain—Gliclazide—type 2 diabetes mellitus	0.000216	0.00161	CcSEcCtD
Aminocaproic Acid—Rash—Glimepiride—type 2 diabetes mellitus	0.000216	0.0016	CcSEcCtD
Aminocaproic Acid—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000215	0.0016	CcSEcCtD
Aminocaproic Acid—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000215	0.0016	CcSEcCtD
Aminocaproic Acid—Rash—Sitagliptin—type 2 diabetes mellitus	0.000215	0.0016	CcSEcCtD
Aminocaproic Acid—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000215	0.0016	CcSEcCtD
Aminocaproic Acid—Headache—Glimepiride—type 2 diabetes mellitus	0.000214	0.00159	CcSEcCtD
Aminocaproic Acid—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000214	0.00159	CcSEcCtD
Aminocaproic Acid—Headache—Sitagliptin—type 2 diabetes mellitus	0.000213	0.00159	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000212	0.00158	CcSEcCtD
Aminocaproic Acid—Oedema—Metformin—type 2 diabetes mellitus	0.000212	0.00158	CcSEcCtD
Aminocaproic Acid—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000212	0.00158	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000211	0.00157	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000209	0.00156	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000209	0.00155	CcSEcCtD
Aminocaproic Acid—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000209	0.00155	CcSEcCtD
Aminocaproic Acid—Shock—Metformin—type 2 diabetes mellitus	0.000208	0.00155	CcSEcCtD
Aminocaproic Acid—Malaise—Losartan—type 2 diabetes mellitus	0.000208	0.00155	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000208	0.00155	CcSEcCtD
Aminocaproic Acid—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000207	0.00154	CcSEcCtD
Aminocaproic Acid—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000207	0.00154	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000207	0.00154	CcSEcCtD
Aminocaproic Acid—Syncope—Losartan—type 2 diabetes mellitus	0.000207	0.00154	CcSEcCtD
Aminocaproic Acid—Leukopenia—Losartan—type 2 diabetes mellitus	0.000206	0.00154	CcSEcCtD
Aminocaproic Acid—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000206	0.00153	CcSEcCtD
Aminocaproic Acid—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000204	0.00152	CcSEcCtD
Aminocaproic Acid—Nausea—Glimepiride—type 2 diabetes mellitus	0.000203	0.00151	CcSEcCtD
Aminocaproic Acid—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000203	0.00151	CcSEcCtD
Aminocaproic Acid—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000202	0.00151	CcSEcCtD
Aminocaproic Acid—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.0002	0.00149	CcSEcCtD
Aminocaproic Acid—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.0002	0.00149	CcSEcCtD
Aminocaproic Acid—Oedema—Irbesartan—type 2 diabetes mellitus	0.0002	0.00149	CcSEcCtD
Aminocaproic Acid—Pruritus—Glyburide—type 2 diabetes mellitus	0.000199	0.00148	CcSEcCtD
Aminocaproic Acid—Hypotension—Metformin—type 2 diabetes mellitus	0.000198	0.00147	CcSEcCtD
Aminocaproic Acid—Shock—Irbesartan—type 2 diabetes mellitus	0.000197	0.00146	CcSEcCtD
Aminocaproic Acid—Pain—Orlistat—type 2 diabetes mellitus	0.000197	0.00146	CcSEcCtD
Aminocaproic Acid—Myalgia—Losartan—type 2 diabetes mellitus	0.000196	0.00146	CcSEcCtD
Aminocaproic Acid—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000196	0.00146	CcSEcCtD
Aminocaproic Acid—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000196	0.00146	CcSEcCtD
Aminocaproic Acid—Rash—Bromocriptine—type 2 diabetes mellitus	0.000194	0.00145	CcSEcCtD
Aminocaproic Acid—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000194	0.00145	CcSEcCtD
Aminocaproic Acid—Discomfort—Losartan—type 2 diabetes mellitus	0.000194	0.00144	CcSEcCtD
Aminocaproic Acid—Headache—Bromocriptine—type 2 diabetes mellitus	0.000193	0.00144	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000193	0.00144	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000193	0.00144	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.00019	0.00142	CcSEcCtD
Aminocaproic Acid—Confusional state—Losartan—type 2 diabetes mellitus	0.00019	0.00141	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000189	0.00141	CcSEcCtD
Aminocaproic Acid—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000189	0.00141	CcSEcCtD
Aminocaproic Acid—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000188	0.0014	CcSEcCtD
Aminocaproic Acid—Oedema—Losartan—type 2 diabetes mellitus	0.000188	0.0014	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000188	0.0014	CcSEcCtD
Aminocaproic Acid—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000187	0.00139	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000187	0.00139	CcSEcCtD
Aminocaproic Acid—Shock—Losartan—type 2 diabetes mellitus	0.000185	0.00138	CcSEcCtD
Aminocaproic Acid—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000184	0.00137	CcSEcCtD
Aminocaproic Acid—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000184	0.00137	CcSEcCtD
Aminocaproic Acid—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000183	0.00136	CcSEcCtD
Aminocaproic Acid—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000183	0.00136	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000182	0.00136	CcSEcCtD
Aminocaproic Acid—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000182	0.00135	CcSEcCtD
Aminocaproic Acid—Vomiting—Glyburide—type 2 diabetes mellitus	0.000179	0.00133	CcSEcCtD
Aminocaproic Acid—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000179	0.00133	CcSEcCtD
Aminocaproic Acid—Malaise—Ramipril—type 2 diabetes mellitus	0.000178	0.00133	CcSEcCtD
Aminocaproic Acid—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000178	0.00133	CcSEcCtD
Aminocaproic Acid—Rash—Glyburide—type 2 diabetes mellitus	0.000178	0.00132	CcSEcCtD
Aminocaproic Acid—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000178	0.00132	CcSEcCtD
Aminocaproic Acid—Syncope—Ramipril—type 2 diabetes mellitus	0.000177	0.00132	CcSEcCtD
Aminocaproic Acid—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000177	0.00132	CcSEcCtD
Aminocaproic Acid—Headache—Glyburide—type 2 diabetes mellitus	0.000177	0.00131	CcSEcCtD
Aminocaproic Acid—Hypotension—Losartan—type 2 diabetes mellitus	0.000176	0.00131	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000175	0.0013	CcSEcCtD
Aminocaproic Acid—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000174	0.00129	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000173	0.00129	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000173	0.00129	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000171	0.00128	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000171	0.00128	CcSEcCtD
Aminocaproic Acid—Convulsion—Ramipril—type 2 diabetes mellitus	0.000171	0.00127	CcSEcCtD
Aminocaproic Acid—Pain—Irbesartan—type 2 diabetes mellitus	0.000171	0.00127	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000169	0.00126	CcSEcCtD
Aminocaproic Acid—Myalgia—Ramipril—type 2 diabetes mellitus	0.000168	0.00125	CcSEcCtD
Aminocaproic Acid—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000168	0.00125	CcSEcCtD
Aminocaproic Acid—Nausea—Glyburide—type 2 diabetes mellitus	0.000167	0.00125	CcSEcCtD
Aminocaproic Acid—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000167	0.00125	CcSEcCtD
Aminocaproic Acid—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000167	0.00125	CcSEcCtD
Aminocaproic Acid—Discomfort—Ramipril—type 2 diabetes mellitus	0.000166	0.00124	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000165	0.00123	CcSEcCtD
Aminocaproic Acid—Pruritus—Valsartan—type 2 diabetes mellitus	0.000165	0.00122	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000163	0.00122	CcSEcCtD
Aminocaproic Acid—Confusional state—Ramipril—type 2 diabetes mellitus	0.000163	0.00121	CcSEcCtD
Aminocaproic Acid—Pruritus—Orlistat—type 2 diabetes mellitus	0.000163	0.00121	CcSEcCtD
Aminocaproic Acid—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000161	0.0012	CcSEcCtD
Aminocaproic Acid—Oedema—Ramipril—type 2 diabetes mellitus	0.000161	0.0012	CcSEcCtD
Aminocaproic Acid—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000161	0.0012	CcSEcCtD
Aminocaproic Acid—Pain—Losartan—type 2 diabetes mellitus	0.000161	0.0012	CcSEcCtD
Aminocaproic Acid—Rash—Gliclazide—type 2 diabetes mellitus	0.00016	0.00119	CcSEcCtD
Aminocaproic Acid—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000159	0.00119	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000159	0.00118	CcSEcCtD
Aminocaproic Acid—Shock—Ramipril—type 2 diabetes mellitus	0.000159	0.00118	CcSEcCtD
Aminocaproic Acid—Headache—Gliclazide—type 2 diabetes mellitus	0.000159	0.00118	CcSEcCtD
Aminocaproic Acid—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000158	0.00118	CcSEcCtD
Aminocaproic Acid—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000158	0.00118	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000157	0.00117	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000155	0.00115	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000154	0.00114	CcSEcCtD
Aminocaproic Acid—Dizziness—Valsartan—type 2 diabetes mellitus	0.000154	0.00114	CcSEcCtD
Aminocaproic Acid—Dizziness—Orlistat—type 2 diabetes mellitus	0.000152	0.00113	CcSEcCtD
Aminocaproic Acid—Hypotension—Ramipril—type 2 diabetes mellitus	0.000151	0.00112	CcSEcCtD
Aminocaproic Acid—Nausea—Gliclazide—type 2 diabetes mellitus	0.00015	0.00112	CcSEcCtD
Aminocaproic Acid—Pruritus—Metformin—type 2 diabetes mellitus	0.00015	0.00112	CcSEcCtD
Aminocaproic Acid—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000149	0.00111	CcSEcCtD
Aminocaproic Acid—Vomiting—Valsartan—type 2 diabetes mellitus	0.000148	0.0011	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000147	0.0011	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000147	0.00109	CcSEcCtD
Aminocaproic Acid—Rash—Valsartan—type 2 diabetes mellitus	0.000147	0.00109	CcSEcCtD
Aminocaproic Acid—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000147	0.00109	CcSEcCtD
Aminocaproic Acid—Vomiting—Orlistat—type 2 diabetes mellitus	0.000146	0.00109	CcSEcCtD
Aminocaproic Acid—Headache—Valsartan—type 2 diabetes mellitus	0.000146	0.00108	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000145	0.00108	CcSEcCtD
Aminocaproic Acid—Rash—Orlistat—type 2 diabetes mellitus	0.000145	0.00108	CcSEcCtD
Aminocaproic Acid—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000145	0.00108	CcSEcCtD
Aminocaproic Acid—Headache—Orlistat—type 2 diabetes mellitus	0.000144	0.00107	CcSEcCtD
Aminocaproic Acid—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000144	0.00107	CcSEcCtD
Aminocaproic Acid—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000141	0.00105	CcSEcCtD
Aminocaproic Acid—Dizziness—Metformin—type 2 diabetes mellitus	0.00014	0.00104	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000139	0.00103	CcSEcCtD
Aminocaproic Acid—Nausea—Valsartan—type 2 diabetes mellitus	0.000138	0.00103	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000137	0.00102	CcSEcCtD
Aminocaproic Acid—Nausea—Orlistat—type 2 diabetes mellitus	0.000137	0.00102	CcSEcCtD
Aminocaproic Acid—Vomiting—Metformin—type 2 diabetes mellitus	0.000135	0.001	CcSEcCtD
Aminocaproic Acid—Rash—Metformin—type 2 diabetes mellitus	0.000134	0.000994	CcSEcCtD
Aminocaproic Acid—Dermatitis—Metformin—type 2 diabetes mellitus	0.000133	0.000993	CcSEcCtD
Aminocaproic Acid—Pruritus—Losartan—type 2 diabetes mellitus	0.000133	0.000991	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000133	0.000989	CcSEcCtD
Aminocaproic Acid—Headache—Metformin—type 2 diabetes mellitus	0.000133	0.000988	CcSEcCtD
Aminocaproic Acid—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000132	0.000984	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000132	0.000982	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000129	0.000958	CcSEcCtD
Aminocaproic Acid—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000128	0.000949	CcSEcCtD
Aminocaproic Acid—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000127	0.000946	CcSEcCtD
Aminocaproic Acid—Rash—Irbesartan—type 2 diabetes mellitus	0.000126	0.000938	CcSEcCtD
Aminocaproic Acid—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000126	0.000937	CcSEcCtD
Aminocaproic Acid—Nausea—Metformin—type 2 diabetes mellitus	0.000126	0.000936	CcSEcCtD
Aminocaproic Acid—Headache—Irbesartan—type 2 diabetes mellitus	0.000125	0.000932	CcSEcCtD
Aminocaproic Acid—Dizziness—Losartan—type 2 diabetes mellitus	0.000124	0.000926	CcSEcCtD
Aminocaproic Acid—Vomiting—Losartan—type 2 diabetes mellitus	0.00012	0.00089	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000119	0.000885	CcSEcCtD
Aminocaproic Acid—Nausea—Irbesartan—type 2 diabetes mellitus	0.000119	0.000884	CcSEcCtD
Aminocaproic Acid—Rash—Losartan—type 2 diabetes mellitus	0.000119	0.000883	CcSEcCtD
Aminocaproic Acid—Dermatitis—Losartan—type 2 diabetes mellitus	0.000119	0.000882	CcSEcCtD
Aminocaproic Acid—Headache—Losartan—type 2 diabetes mellitus	0.000118	0.000877	CcSEcCtD
Aminocaproic Acid—Pruritus—Ramipril—type 2 diabetes mellitus	0.000114	0.000849	CcSEcCtD
Aminocaproic Acid—Nausea—Losartan—type 2 diabetes mellitus	0.000112	0.000832	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.00011	0.000821	CcSEcCtD
Aminocaproic Acid—Dizziness—Ramipril—type 2 diabetes mellitus	0.000107	0.000794	CcSEcCtD
Aminocaproic Acid—Vomiting—Ramipril—type 2 diabetes mellitus	0.000103	0.000763	CcSEcCtD
Aminocaproic Acid—Rash—Ramipril—type 2 diabetes mellitus	0.000102	0.000757	CcSEcCtD
Aminocaproic Acid—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000102	0.000756	CcSEcCtD
Aminocaproic Acid—Headache—Ramipril—type 2 diabetes mellitus	0.000101	0.000752	CcSEcCtD
Aminocaproic Acid—Nausea—Ramipril—type 2 diabetes mellitus	9.58e-05	0.000713	CcSEcCtD
Aminocaproic Acid—AOX1—Disease—SPRY2—type 2 diabetes mellitus	4.26e-05	0.0003	CbGpPWpGaD
Aminocaproic Acid—PLG—Metabolism of proteins—LEP—type 2 diabetes mellitus	4.21e-05	0.000296	CbGpPWpGaD
Aminocaproic Acid—PLG—Hemostasis—SERPINE1—type 2 diabetes mellitus	4.2e-05	0.000296	CbGpPWpGaD
Aminocaproic Acid—PLAT—Hemostasis—SERPINE1—type 2 diabetes mellitus	4.2e-05	0.000296	CbGpPWpGaD
Aminocaproic Acid—PLG—Hemostasis—ALB—type 2 diabetes mellitus	4.19e-05	0.000295	CbGpPWpGaD
Aminocaproic Acid—PLAT—Hemostasis—ALB—type 2 diabetes mellitus	4.19e-05	0.000295	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling by PDGF—AKT1—type 2 diabetes mellitus	4.18e-05	0.000294	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling by PDGF—AKT1—type 2 diabetes mellitus	4.18e-05	0.000294	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—RBP4—type 2 diabetes mellitus	4.16e-05	0.000292	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	4.12e-05	0.00029	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	4.12e-05	0.00029	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	4.08e-05	0.000287	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—SPRY2—type 2 diabetes mellitus	4.08e-05	0.000287	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—SPRY2—type 2 diabetes mellitus	4.08e-05	0.000287	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	4.08e-05	0.000287	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—HK1—type 2 diabetes mellitus	4.04e-05	0.000284	CbGpPWpGaD
Aminocaproic Acid—PLAT—Hemostasis—PIK3R1—type 2 diabetes mellitus	4.01e-05	0.000282	CbGpPWpGaD
Aminocaproic Acid—PLG—Hemostasis—NOS3—type 2 diabetes mellitus	4.01e-05	0.000282	CbGpPWpGaD
Aminocaproic Acid—PLG—Hemostasis—PIK3R1—type 2 diabetes mellitus	4.01e-05	0.000282	CbGpPWpGaD
Aminocaproic Acid—PLAT—Hemostasis—NOS3—type 2 diabetes mellitus	4.01e-05	0.000282	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—RBP4—type 2 diabetes mellitus	3.98e-05	0.00028	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—RBP4—type 2 diabetes mellitus	3.98e-05	0.00028	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—GLP1R—type 2 diabetes mellitus	3.98e-05	0.00028	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—GLP1R—type 2 diabetes mellitus	3.98e-05	0.00028	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—CCKAR—type 2 diabetes mellitus	3.92e-05	0.000276	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—CCKAR—type 2 diabetes mellitus	3.92e-05	0.000276	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—KCNJ11—type 2 diabetes mellitus	3.9e-05	0.000275	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—GCKR—type 2 diabetes mellitus	3.9e-05	0.000275	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—LPA—type 2 diabetes mellitus	3.9e-05	0.000275	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—HSD3B2—type 2 diabetes mellitus	3.9e-05	0.000275	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—SLC2A2—type 2 diabetes mellitus	3.88e-05	0.000273	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—MTR—type 2 diabetes mellitus	3.8e-05	0.000267	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—ALDOB—type 2 diabetes mellitus	3.74e-05	0.000263	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—NAMPT—type 2 diabetes mellitus	3.73e-05	0.000262	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—GCK—type 2 diabetes mellitus	3.7e-05	0.000261	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—IAPP—type 2 diabetes mellitus	3.68e-05	0.000259	CbGpPWpGaD
Aminocaproic Acid—PLG—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	3.63e-05	0.000255	CbGpPWpGaD
Aminocaproic Acid—PLAT—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	3.63e-05	0.000255	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—SLC9A1—type 2 diabetes mellitus	3.62e-05	0.000254	CbGpPWpGaD
Aminocaproic Acid—PLG—Metabolism of proteins—INS—type 2 diabetes mellitus	3.6e-05	0.000253	CbGpPWpGaD
Aminocaproic Acid—PLG—Platelet activation, signaling and aggregation—AKT1—type 2 diabetes mellitus	3.58e-05	0.000252	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	3.55e-05	0.00025	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	3.55e-05	0.00025	CbGpPWpGaD
Aminocaproic Acid—PLG—Metabolism of proteins—CCL2—type 2 diabetes mellitus	3.54e-05	0.000249	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—IAPP—type 2 diabetes mellitus	3.53e-05	0.000248	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—IAPP—type 2 diabetes mellitus	3.53e-05	0.000248	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—INSR—type 2 diabetes mellitus	3.5e-05	0.000247	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—INSR—type 2 diabetes mellitus	3.5e-05	0.000247	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—GLP1R—type 2 diabetes mellitus	3.48e-05	0.000245	CbGpPWpGaD
Aminocaproic Acid—PLG—Metabolism of proteins—IGF1—type 2 diabetes mellitus	3.48e-05	0.000245	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—TRPC6—type 2 diabetes mellitus	3.44e-05	0.000242	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—TRPC6—type 2 diabetes mellitus	3.44e-05	0.000242	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—AGTR2—type 2 diabetes mellitus	3.42e-05	0.000241	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—AGTR2—type 2 diabetes mellitus	3.42e-05	0.000241	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—HMGA1—type 2 diabetes mellitus	3.39e-05	0.000238	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—PSMD6—type 2 diabetes mellitus	3.32e-05	0.000234	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—SNAP25—type 2 diabetes mellitus	3.32e-05	0.000234	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—EDNRB—type 2 diabetes mellitus	3.28e-05	0.000231	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—EDNRB—type 2 diabetes mellitus	3.28e-05	0.000231	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—SLC2A2—type 2 diabetes mellitus	3.25e-05	0.000229	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—CYBA—type 2 diabetes mellitus	3.22e-05	0.000226	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—CPT1A—type 2 diabetes mellitus	3.18e-05	0.000224	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—MTR—type 2 diabetes mellitus	3.18e-05	0.000224	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—PSMD6—type 2 diabetes mellitus	3.18e-05	0.000224	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—PSMD6—type 2 diabetes mellitus	3.18e-05	0.000224	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—HTR2C—type 2 diabetes mellitus	3.18e-05	0.000224	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—HTR2C—type 2 diabetes mellitus	3.18e-05	0.000224	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—NAMPT—type 2 diabetes mellitus	3.12e-05	0.00022	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—CALCA—type 2 diabetes mellitus	3.11e-05	0.000219	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—LIPC—type 2 diabetes mellitus	3.1e-05	0.000218	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—HBA1—type 2 diabetes mellitus	3.1e-05	0.000218	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—GCK—type 2 diabetes mellitus	3.1e-05	0.000218	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—EDNRA—type 2 diabetes mellitus	3.1e-05	0.000218	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—EDNRA—type 2 diabetes mellitus	3.1e-05	0.000218	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—CYP11A1—type 2 diabetes mellitus	3.08e-05	0.000217	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—CYBA—type 2 diabetes mellitus	3.08e-05	0.000217	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—CYBA—type 2 diabetes mellitus	3.08e-05	0.000217	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	3.03e-05	0.000213	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	3.03e-05	0.000213	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—SLC9A1—type 2 diabetes mellitus	3.03e-05	0.000213	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—GHRL—type 2 diabetes mellitus	3.02e-05	0.000212	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—GHRL—type 2 diabetes mellitus	3.02e-05	0.000212	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—PLAT—type 2 diabetes mellitus	3.02e-05	0.000212	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—SLC2A1—type 2 diabetes mellitus	3e-05	0.000211	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—CETP—type 2 diabetes mellitus	2.99e-05	0.000211	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—CALCA—type 2 diabetes mellitus	2.98e-05	0.00021	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—CALCA—type 2 diabetes mellitus	2.98e-05	0.00021	CbGpPWpGaD
Aminocaproic Acid—PLG—Hemostasis—SRC—type 2 diabetes mellitus	2.97e-05	0.000209	CbGpPWpGaD
Aminocaproic Acid—PLAT—Hemostasis—SRC—type 2 diabetes mellitus	2.97e-05	0.000209	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—NOS1—type 2 diabetes mellitus	2.96e-05	0.000208	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—TCF7L2—type 2 diabetes mellitus	2.93e-05	0.000206	CbGpPWpGaD
Aminocaproic Acid—PLG—Hemostasis—VEGFA—type 2 diabetes mellitus	2.89e-05	0.000203	CbGpPWpGaD
Aminocaproic Acid—PLAT—Hemostasis—VEGFA—type 2 diabetes mellitus	2.89e-05	0.000203	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—SLC2A4—type 2 diabetes mellitus	2.88e-05	0.000203	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	2.81e-05	0.000197	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	2.81e-05	0.000197	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—PSMD6—type 2 diabetes mellitus	2.78e-05	0.000196	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—SREBF1—type 2 diabetes mellitus	2.78e-05	0.000196	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—SNAP25—type 2 diabetes mellitus	2.78e-05	0.000196	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—PTPN1—type 2 diabetes mellitus	2.76e-05	0.000194	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—PTPN1—type 2 diabetes mellitus	2.76e-05	0.000194	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—GCG—type 2 diabetes mellitus	2.76e-05	0.000194	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—GCG—type 2 diabetes mellitus	2.76e-05	0.000194	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—CTGF—type 2 diabetes mellitus	2.73e-05	0.000192	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	2.71e-05	0.000191	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	2.71e-05	0.000191	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—HMGCR—type 2 diabetes mellitus	2.71e-05	0.00019	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	2.71e-05	0.00019	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	2.71e-05	0.00019	CbGpPWpGaD
Aminocaproic Acid—PLG—Hemostasis—TGFB1—type 2 diabetes mellitus	2.65e-05	0.000187	CbGpPWpGaD
Aminocaproic Acid—PLAT—Hemostasis—TGFB1—type 2 diabetes mellitus	2.65e-05	0.000187	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—ADRA2A—type 2 diabetes mellitus	2.65e-05	0.000186	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—CYP2E1—type 2 diabetes mellitus	2.54e-05	0.000179	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—CYP1A2—type 2 diabetes mellitus	2.52e-05	0.000177	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—SLC2A1—type 2 diabetes mellitus	2.52e-05	0.000177	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—TGFBR2—type 2 diabetes mellitus	2.51e-05	0.000176	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—CYP3A4—type 2 diabetes mellitus	2.45e-05	0.000173	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—CDKN2B—type 2 diabetes mellitus	2.43e-05	0.000171	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—GCG—type 2 diabetes mellitus	2.41e-05	0.00017	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—SLC2A4—type 2 diabetes mellitus	2.41e-05	0.00017	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	2.4e-05	0.000169	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	2.4e-05	0.000169	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—GNB3—type 2 diabetes mellitus	2.38e-05	0.000167	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—GNB3—type 2 diabetes mellitus	2.38e-05	0.000167	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—APOB—type 2 diabetes mellitus	2.37e-05	0.000167	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—MMP3—type 2 diabetes mellitus	2.35e-05	0.000165	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—MMP3—type 2 diabetes mellitus	2.35e-05	0.000165	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—AVP—type 2 diabetes mellitus	2.35e-05	0.000165	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—AVP—type 2 diabetes mellitus	2.35e-05	0.000165	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—IGF2—type 2 diabetes mellitus	2.34e-05	0.000164	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—IGF2—type 2 diabetes mellitus	2.34e-05	0.000164	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	2.33e-05	0.000164	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	2.33e-05	0.000164	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—APOB—type 2 diabetes mellitus	2.27e-05	0.00016	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—APOB—type 2 diabetes mellitus	2.27e-05	0.00016	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—LPL—type 2 diabetes mellitus	2.26e-05	0.000159	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—IGF1R—type 2 diabetes mellitus	2.26e-05	0.000159	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—IGF1R—type 2 diabetes mellitus	2.26e-05	0.000159	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—EDN1—type 2 diabetes mellitus	2.23e-05	0.000157	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—EDN1—type 2 diabetes mellitus	2.23e-05	0.000157	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—ADCY5—type 2 diabetes mellitus	2.21e-05	0.000156	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—LPL—type 2 diabetes mellitus	2.16e-05	0.000152	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—LPL—type 2 diabetes mellitus	2.16e-05	0.000152	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—PPP2CA—type 2 diabetes mellitus	2.12e-05	0.000149	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—ADCY5—type 2 diabetes mellitus	2.12e-05	0.000149	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—ADCY5—type 2 diabetes mellitus	2.12e-05	0.000149	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—CCR5—type 2 diabetes mellitus	2.08e-05	0.000147	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.08e-05	0.000146	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—GNB3—type 2 diabetes mellitus	2.08e-05	0.000146	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—HMOX1—type 2 diabetes mellitus	2.07e-05	0.000146	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—CAT—type 2 diabetes mellitus	2.04e-05	0.000144	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—MTHFR—type 2 diabetes mellitus	2.04e-05	0.000143	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	2.03e-05	0.000143	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	2.03e-05	0.000143	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.99e-05	0.00014	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.99e-05	0.00014	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—APOB—type 2 diabetes mellitus	1.98e-05	0.00014	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—C3—type 2 diabetes mellitus	1.95e-05	0.000137	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—C3—type 2 diabetes mellitus	1.95e-05	0.000137	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—HIF1A—type 2 diabetes mellitus	1.94e-05	0.000137	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—IRS2—type 2 diabetes mellitus	1.94e-05	0.000136	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—GSTM1—type 2 diabetes mellitus	1.93e-05	0.000136	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—CALM1—type 2 diabetes mellitus	1.9e-05	0.000134	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—APOE—type 2 diabetes mellitus	1.89e-05	0.000133	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—LPL—type 2 diabetes mellitus	1.89e-05	0.000133	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—APOA1—type 2 diabetes mellitus	1.87e-05	0.000132	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.86e-05	0.000131	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.86e-05	0.000131	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.85e-05	0.00013	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.85e-05	0.00013	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—ADCY5—type 2 diabetes mellitus	1.85e-05	0.00013	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—AGT—type 2 diabetes mellitus	1.85e-05	0.00013	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—AGT—type 2 diabetes mellitus	1.85e-05	0.00013	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—GPX1—type 2 diabetes mellitus	1.85e-05	0.00013	CbGpPWpGaD
Aminocaproic Acid—PLAT—Hemostasis—AKT1—type 2 diabetes mellitus	1.84e-05	0.00013	CbGpPWpGaD
Aminocaproic Acid—PLG—Hemostasis—AKT1—type 2 diabetes mellitus	1.84e-05	0.00013	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.82e-05	0.000128	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.82e-05	0.000128	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—APOE—type 2 diabetes mellitus	1.81e-05	0.000128	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—LEP—type 2 diabetes mellitus	1.81e-05	0.000128	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—APOE—type 2 diabetes mellitus	1.81e-05	0.000128	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—LEP—type 2 diabetes mellitus	1.81e-05	0.000128	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—CD36—type 2 diabetes mellitus	1.8e-05	0.000127	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.79e-05	0.000126	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.79e-05	0.000126	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.78e-05	0.000125	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—NOS2—type 2 diabetes mellitus	1.77e-05	0.000124	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.71e-05	0.00012	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.71e-05	0.00012	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—MTHFR—type 2 diabetes mellitus	1.7e-05	0.00012	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—IRS1—type 2 diabetes mellitus	1.69e-05	0.000119	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—PPARA—type 2 diabetes mellitus	1.67e-05	0.000118	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—AGT—type 2 diabetes mellitus	1.62e-05	0.000114	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.62e-05	0.000114	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.62e-05	0.000114	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—INS—type 2 diabetes mellitus	1.62e-05	0.000114	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—CALM1—type 2 diabetes mellitus	1.59e-05	0.000112	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—APOE—type 2 diabetes mellitus	1.59e-05	0.000112	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—APOA1—type 2 diabetes mellitus	1.57e-05	0.00011	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—AKT2—type 2 diabetes mellitus	1.56e-05	0.00011	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—INS—type 2 diabetes mellitus	1.55e-05	0.000109	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—INS—type 2 diabetes mellitus	1.55e-05	0.000109	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.53e-05	0.000107	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.53e-05	0.000107	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.5e-05	0.000106	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.5e-05	0.000106	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.5e-05	0.000105	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.5e-05	0.000105	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—SERPINE1—type 2 diabetes mellitus	1.49e-05	0.000105	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.42e-05	0.0001	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.42e-05	0.0001	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—NOS3—type 2 diabetes mellitus	1.42e-05	9.99e-05	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—PIK3R1—type 2 diabetes mellitus	1.42e-05	9.99e-05	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—PPARG—type 2 diabetes mellitus	1.38e-05	9.73e-05	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.36e-05	9.57e-05	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.36e-05	9.57e-05	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.36e-05	9.57e-05	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.36e-05	9.57e-05	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—INS—type 2 diabetes mellitus	1.36e-05	9.54e-05	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—PTGS2—type 2 diabetes mellitus	1.3e-05	9.14e-05	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—RELA—type 2 diabetes mellitus	1.28e-05	9e-05	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—RELA—type 2 diabetes mellitus	1.28e-05	9e-05	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—ALB—type 2 diabetes mellitus	1.24e-05	8.74e-05	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.19e-05	8.36e-05	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—NOS3—type 2 diabetes mellitus	1.19e-05	8.36e-05	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.15e-05	8.12e-05	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.15e-05	8.12e-05	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.09e-05	7.67e-05	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.09e-05	7.67e-05	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—PTGS2—type 2 diabetes mellitus	1.09e-05	7.65e-05	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.08e-05	7.59e-05	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.08e-05	7.59e-05	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—SRC—type 2 diabetes mellitus	1.05e-05	7.39e-05	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—SRC—type 2 diabetes mellitus	1.01e-05	7.08e-05	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—SRC—type 2 diabetes mellitus	1.01e-05	7.08e-05	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.79e-06	6.89e-05	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.79e-06	6.89e-05	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—TGFB1—type 2 diabetes mellitus	9.39e-06	6.6e-05	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—EGFR—type 2 diabetes mellitus	9.2e-06	6.48e-05	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.99e-06	6.33e-05	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.99e-06	6.33e-05	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.81e-06	6.2e-05	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.81e-06	6.2e-05	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—IL6—type 2 diabetes mellitus	7.07e-06	4.98e-05	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—IL6—type 2 diabetes mellitus	6.77e-06	4.77e-05	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—IL6—type 2 diabetes mellitus	6.77e-06	4.77e-05	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—AKT1—type 2 diabetes mellitus	6.52e-06	4.59e-05	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.25e-06	4.4e-05	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.25e-06	4.4e-05	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—AKT1—type 2 diabetes mellitus	5.46e-06	3.85e-05	CbGpPWpGaD
